Format

Send to

Choose Destination
Haematologica. 2018 Mar;103(3):477-485. doi: 10.3324/haematol.2017.177972. Epub 2017 Dec 14.

Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

Author information

1
NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen.
2
NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig University, Giessen Christine.Damm-Welk@paediat.med.uni-giessen.de.
3
Department of Pediatric Hematology and Oncology, Children's Hospital, Hannover Medical School, Germany.

Abstract

Patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma often present with B-symptoms or hemophagocytosis and generate an anti-tumor immune response. Specific serum cytokine levels or profiles may reflect the tumor burden, non-specific immune stimulation by the tumor or differences in the strength of the patients' anti-lymphoma immunity. We systematically correlated pretreatment concentrations of 25 cytokines with clinical and biological characteristics in a well-characterized cohort of 119 uniformly treated pediatric patients with anaplastic large cell lymphoma. Fifteen patients with anaplastic large cell lymphoma in remission and 11 patients with low-stage B-cell lymphoma served as controls. Concentrations of interleukin-9, interleukin-10, interleukin-17a, hepatocyte growth factor, soluble interleukin-2 receptor, and soluble CD30 were significantly higher in initial sera of patients than in the sera of subjects from both control groups, indicating an anaplastic large cell lymphoma-type cytokine signature. The levels of interleukin-6, interferon-γ, interferon γ-induced protein, and soluble interleukin-2 receptor correlated with the stage, initial general condition, minimal disseminated disease, anaplastic lymphoma kinase-antibody titers, and the risk of relapse among patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Only interleukin-6 showed an independent prognostic value in multivariate analyses. Pretreatment cytokine profiles in patients with anaplastic large cell lymphoma reflect a tumor signature as well as tumor burden and also differences in the strength of the patients' immune response.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center